Vivian Hou Chu, MD

Associate Professor
Member in the Duke Clinical Research Institute
Campus mail Duke Box 102359, DIV of Infectious Diseases, Durham, NC 27710
Phone (919) 668-7174
Email address vivian.chu@duke.edu

Dr. Chu's clinical research is focused on staphylococci and endocarditis (IE).  She is the director of the International Collaboration on Endocarditis (ICE), a group of investigators from 78 sites in 32 countries worldwide that is dedicated to further the understanding of infective endocarditis.  The ICE database comprises > 5000 cases of endocarditis and is designed to answer questions that could not be answered from a single-center study. The current focus of this group is surgical-decision making in the treatment of endocarditis. Another major focus of Dr. Chu's research is on the relationship between oral hygiene and risk for developing infective endocarditis.

Education and Training

  • Fellow in Infectious Diseases, Medicine, Duke University, 2003 - 2006
  • Medical Resident, Medicine, Duke University, 2000 - 2003
  • M.D., Columbia University, 2000

Publications

Morpeth, Susan, David Murdoch, Christopher H. Cabell, Adolf W. Karchmer, Paul Pappas, Donald Levine, Francisco Nacinovich, et al. “Non-HACEK gram-negative bacillus endocarditis..” Ann Intern Med 147, no. 12 (December 18, 2007): 829–35. https://doi.org/10.7326/0003-4819-147-12-200712180-00002.

PMID
18087053
Full Text

Stryjewski, Martin E., Russell P. Hall, Vivian H. Chu, Zeina A. Kanafani, William D. O’Riordan, Michael S. Weinstock, R Scott Stienecker, et al. “Expression of antimicrobial peptides in the normal and involved skin of patients with infective cellulitis..” J Infect Dis 196, no. 9 (November 1, 2007): 1425–30. https://doi.org/10.1086/522630.

PMID
17922409
Full Text

Chu, Vivian H., and Arnold S. Bayer. “Use of echocardiography in the diagnosis and management of infective endocarditis..” Curr Infect Dis Rep 9, no. 4 (July 2007): 283–90.

PMID
17618547
Scholars@Duke

Aksoy, Olcay, Daniel J. Sexton, Andrew Wang, Paul A. Pappas, Wissam Kourany, Vivian Chu, Vance G. Fowler, et al. “Early surgery in patients with infective endocarditis: a propensity score analysis..” Clin Infect Dis 44, no. 3 (February 1, 2007): 364–72. https://doi.org/10.1086/510583.

PMID
17205442
Full Text

Stryjewski, Martin E., Lynda A. Szczech, Daniel K. Benjamin, Jula K. Inrig, Zeina A. Kanafani, John J. Engemann, Vivian H. Chu, et al. “Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia..” Clin Infect Dis 44, no. 2 (January 15, 2007): 190–96. https://doi.org/10.1086/510386.

PMID
17173215
Full Text

Lalani, T., Z. A. Kanafani, V. H. Chu, L. Moore, G. R. Corey, P. Pappas, C. W. Woods, et al. “Prosthetic valve endocarditis due to coagulase-negative staphylococci: findings from the International Collaboration on Endocarditis Merged Database..” Eur J Clin Microbiol Infect Dis 25, no. 6 (June 2006): 365–68. https://doi.org/10.1007/s10096-006-0141-z.

PMID
16767483
Full Text

Stryjewski, Martin E., Vivian H. Chu, William D. O’Riordan, Brian L. Warren, Lala M. Dunbar, David M. Young, Marc Vallée, et al. “Telavancin versus standard therapy for treatment of complicated skin and skin structure infections caused by gram-positive bacteria: FAST 2 study..” Antimicrob Agents Chemother 50, no. 3 (March 2006): 862–67. https://doi.org/10.1128/AAC.50.3.862-867.2006.

PMID
16495243
Full Text

Chu, Vivian H., David R. Crosslin, Joelle Y. Friedman, Shelby D. Reed, Christopher H. Cabell, Robert I. Griffiths, Leah E. Masselink, et al. “Staphylococcus aureus bacteremia in patients with prosthetic devices: costs and outcomes..” Am J Med 118, no. 12 (December 2005). https://doi.org/10.1016/j.amjmed.2005.06.011.

PMID
16378797
Full Text

Chu, Vivian H., Daniel J. Sexton, Christopher H. Cabell, L Barth Reller, Paul A. Pappas, Rakesh K. Singh, Vance G. Fowler, G Ralph Corey, Olcay Aksoy, and Christopher W. Woods. “Repeat infective endocarditis: differentiating relapse from reinfection..” Clin Infect Dis 41, no. 3 (August 1, 2005): 406–9. https://doi.org/10.1086/431590.

PMID
16007540
Full Text

Stryjewski, Martin E., William D. O’Riordan, William K. Lau, Francis D. Pien, Lala M. Dunbar, Marc Vallee, Vance G. Fowler, et al. “Telavancin versus standard therapy for treatment of complicated skin and soft-tissue infections due to gram-positive bacteria..” Clin Infect Dis 40, no. 11 (June 1, 2005): 1601–7. https://doi.org/10.1086/429914.

PMID
15889357
Full Text

Pages